Lv1
100 积分 2023-09-15 加入
High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia
1天前
求助中
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
13天前
已关闭
How to manage waldenström’s macroglobulinemia in 2024
30天前
已完结
Incorporating acalabrutinib, a selective next‐generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies
1个月前
已完结
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement
1个月前
已完结
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
1个月前
已完结
The GLOW trial in chronic lymphocytic leukaemia
2个月前
已完结
The GLOW trial in chronic lymphocytic leukaemia
2个月前
已完结
Prevention and management of infectious complications in patients with chronic leucocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
2个月前
已完结
Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy
2个月前
已完结
皖公网安备34019202002308
